Bivalent CD47 Immunotoxin for Targeted Therapy of Lung Cancer
Jihong Ma, Dinoop Ravindran Menon, Zhaohui Wang, Danielle Mintzlaff, Hugh Rock, Lauren E. Giesy, Christene A. Huang, David W. Mathes, Trevor Nydam, Elizabeth Anne Pomfret, D. Ross Camidge, Hatem E. Sabaawy, Sharon R. Pine, Zhirui Wang
This study develops a bivalent CD47 immunotoxin for NSCLC therapy, showing strong preclinical efficacy in multiple mouse models.
Biomedicines · Sep 26, 2026Peer-reviewedCancer Biology